Article Text
Abstract
Two patients receiving oral etoposide therapy developed Pneumocystis jirovecii pneumonia during chemotherapy with significant lymphopenia without corticosteroid use. In this commentary we discuss cellular mechanisms by which etoposide induced CD4+ T lymphocyte dysfunction and reduced survival may lead to predisposition to P. jirovecii infection.
- malignant disease and immunosuppression
- infections
- haematology (incl blood transfusion)
- pneumonia (infectious disease)
Statistics from Altmetric.com
Footnotes
Contributors PAB and MAM conceived of the presented idea. MAM, JC, SI and PAB created manuscript draft. All authors discussed the results and contributed to the final manuscript.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed.